Fig. 3From: Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapyCumulative incidences of HBV relapse after cessation of antiviral prophylactic entecavir and TAF Groups after propensity score matching for all patients. A virological and B clinical relapseBack to article page